Conference - New York, United States
Demyelinating diseases and disorders affect millions of people worldwide. New breakthroughs in basic science research on the white matter microenvironment and oligodendrocyte precursor cell development have provided novel potential sites of action for therapeutics. Translation of these discoveries into biomarkers to predict clinical outcomes, and into biologics that can modulate myelination utilizing these pathways, may transform the treatment of currently incurable conditions.
This one-day, translational conference will present recent findings in remyelination and repair from disease models and clinical trials, new techniques for imaging myelination changes in the brain and for screening molecular targets, and emerging therapeutics that promote remyelination.
Organization: The New York Academy of Sciences
Demyelination and Remyelination: From Mechanism to Therapy
Thursday, June 26, 2014 (7:45 AM - 6:00 PM)
The New York Academy of Sciences
250 Greenwich Street, 40th Fl, New York, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
